Literature DB >> 9852973

Evidence of latent varicella-zoster virus in rat dorsal root ganglia.

P Annunziato1, P LaRussa, P Lee, S Steinberg, O Lungu, A A Gershon, S Silverstein.   

Abstract

Latent varicella-zoster virus (VZV) was studied in ganglia of rats that had been inoculated subcutaneously with either a high-passaged wild-type, a low-passaged wild-type, or the vaccine strain of virus using in situ hybridization. Nine of 11 rats injected with virus and no control rats developed serum VZV antibodies as demonstrated by fluorescent antibody membrane antigen. Polymerase chain reaction 2 weeks following inoculation did not detect viremia in the rats. VZV was detected by in situ hybridization in ganglia of 10 of the 11 infected rats but not in ganglia of the control rats. The distribution of VZV DNA is identical to that seen in humans; satellite cells and neurons contain VZV DNA. Although all animals received unilateral injections of virus, VZV DNA was in ipsilateral and contralateral ganglia in 6 animals, suggesting that virus replication and viremia had occurred.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852973     DOI: 10.1086/514261

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Varicella-zoster virus open reading frame 2 encodes a membrane phosphoprotein that is dispensable for viral replication and for establishment of latency.

Authors:  Hitoshi Sato; Lesley Pesnicak; Jeffrey I Cohen
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Postentry events are responsible for restriction of productive varicella-zoster virus infection in Chinese hamster ovary cells.

Authors:  Renée L Finnen; Kara R Mizokami; Bruce W Banfield; Guang-Yun Cai; Scott A Simpson; Lewis I Pizer; Myron J Levin
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

Review 3.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

4.  Simian varicella virus pathogenesis.

Authors:  Ravi Mahalingam; Ilhem Messaoudi; Don Gilden
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 5.  Rodent models of varicella-zoster virus neurotropism.

Authors:  Jeffrey I Cohen
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

6.  Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.

Authors:  Christine Meyer; Flora Engelmann; Nicole Arnold; David L Krah; Jan ter Meulen; Kristen Haberthur; Jesse Dewane; Ilhem Messaoudi
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

7.  Clinical and molecular aspects of varicella zoster virus infection.

Authors:  Don Gilden; Maria A Nagel; Ravi Mahalingam; Niklaus H Mueller; Elizabeth A Brazeau; Subbiah Pugazhenthi; Randall J Cohrs
Journal:  Future Neurol       Date:  2009-01-01

8.  The DNA element controlling expression of the varicella-zoster virus open reading frame 28 and 29 genes consists of two divergent unidirectional promoters which have a common USF site.

Authors:  Min Yang; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 9.  Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.

Authors:  Niklaus H Mueller; Donald H Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

10.  Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models.

Authors:  Paul R Kinchington; William F Goins
Journal:  J Neurovirol       Date:  2011-12-28       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.